InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,494.78
(
0.41%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
73.19
(
-1.84%
)
Bitcoin
63,201.73
(
-1.66%
)
Post# of 253222
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

piggerpig

Send PM Follow Ignore
Followers 1
Posts 302
Boards Moderated 0
Alias Born 06/13/2010

piggerpig

Re: None

Thursday, 07/31/2014 5:25:04 AM

Thursday, July 31, 2014 5:25:04 AM

Post# of 253222
ARRY from AZN PR today, notice anticipate first MEK Filling 2015:


selumetinib# SELECT-1
MEK inhibitor 2nd line KRAS+ NSCLC

Q4 2013 Ant. US file 2017 Ant. EU file2017

selumetinib# ASTRA
MEK inhibitor differentiated thyroid cancer

Q3 2013 Ant. US file 2017 Ant. EU file 2017

selumetinib# SUMIT
MEK inhibitor uveal melanoma

Q2 2014 Ant. US file 2015 Ant. EU file 2015
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up